Kymera raises $30M series A

On Oct. 30, Kymera Therapeutics LLC (Cambridge, Mass.) raised $30 million in a series A round led by co-founder investor Atlas Venture. New investors Lilly Ventures and Amgen Ventures

Read the full 298 word article

User Sign In